Want to add some top-notch ASX 200 stocks to your portfolio in July? Then the three listed below could be considered.
I believe these blue chip stocks have the potential to generate solid total returns for investors over the next few years. Here’s why I would buy them next month:
The first premium ASX 200 stock I would consider buying in July is Coles. I think the supermarket giant would be a great option for several reasons. These include its defensive profits, its solid market position, and the new strategy unveiled last year. This strategy aims to achieve $ 1 billion in cumulative savings by 2023 through the use of technology to automate manual tasks and simplify roles above the store. I believe this leaves Coles well positioned to achieve solid growth in profits and dividends over the next decade.
Another top notch ASX 200 title to consider buying is Ramsay Health Care. While the short term is likely to be difficult, I think Ramsay’s long-term growth potential remains very solid. Indeed, the company world-class network of private hospitals appears to benefit from the projected increase in demand for health services in the future due to an aging population and an increase in chronic diseases. Another positive point is Ramsay’s long history of making profitable acquisitions. I think there is a good chance that it will acquire its place in new markets in the coming years to support its growth. Overall, I think it puts him in a solid position to deliver solid total returns to investors in the 2020s and beyond.
One last piece of ASX 200 chip to consider buying is this giant job listing. As with Ramsay, SEEK is certainly struggling right now. But I don’t think it will be long before business conditions normalize and society returns to growth. As far as the latter is concerned, I believe that its activity in China, Zhaopin, will be the main driver of growth in the future. This activity quickly became the centerpiece of the company and contributed 47.8% of its total turnover in the first half of fiscal 2020. Given the profitability of the Chinese market, I am convinced that Zhaopin can sustain strong growth for SEEK for a long time to come.
Motley Fool resident securities expert Dr Anirban Mahanti stumbled across three under-the-radar stock picks which he believes could be among the greatest discoveries of his investment career.
He is so confident in their future prospects that he published “double“buy alerts on each of these three stocks from members of his Motley Fool Extreme Opportunities stock selection service.
* Extreme Opportunities returns from June 5, 2020
Motley Fool donor James Mickleboro owns shares of SEEK Limited. The Motley Fool Australia holds shares of COLESGROUP DEF SET. The Motley Fool Australia recommended Ramsay Health Care Limited and SEEK Limited. We fools may not all share the same opinion, but we all think that varied range of perspectives makes us better investors. The Motley Fool has a disclosure policy. This article only contains general investment advice (under AFSL 400691). Authorized by Scott Phillips.